DARC Technology combines a biomarker with an AI algorithm to de-risk clinical development, improving study outcomes whilst reducing time to market & costs for glaucoma & AMD therapeutics. We are ILLUSTRATUM, a British biotechnology company who are commercialising DARC Technology, developed by Professor M Francesca Cordeiro through Wellcome Trust funding. Francesca Cordeiro is a Professor at UCL Institute of Ophthalmology and Imperial College London and is Director of the clinical trials unit at The Western Eye Hospital.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
DARC Technology Biomarker
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):